Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07231523 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trial| NCT Number | NCT07231523 |
| Lead Sponsor | Shanghai Zhongshan Hospital
Collaborators: The Affiliated Hospital of Xuzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Tang-Du Hospital, West China Hospital, Second Affiliated Hospital of Soochow University, Huashan Hospital, The Affiliated Brain Hospital of Nanjing Medical University, The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Wuhan TongJi Hospital |
| Conditions (from sponsor) |
Efgartigimod, Intravenous Immunoglobulin, Myasthenia Gravis Associated With Thymoma |
| Enrollment | 64 participants |
| Start Date | |
| Primary Completion | (estimated) |
| Study Completion | (estimated) |
| Updated on ClinicalTrials.gov |